OAC
COGT icon

OMERS Administration Corp’s Cogent Biosciences COGT Stock Holding History

OMERS Administration Corp’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-30,300
Closed -$236K – 1050
2024
Q4 		$236K Buy
+30,300
New +$302K ﹤0.01% 858

Other funds holding COGT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

OMERS Administration Corp's COGT Position: Q1 2025 in Review

OMERS Administration Corp sold out of Cogent Biosciences (COGT) in Q1 2025, closing a stake of 30,300 shares — an estimated $236K sold.

OMERS Administration Corp first reported a position in COGT in Q4 2024 and held it in 1 quarter. The position peaked at $236K in Q4 2024. 186 funds tracked by Wall St. Rank hold COGT as of Q1 2025.

  • OMERS Administration Corp reported no remaining Cogent Biosciences position as of Q1 2025 after selling out during the quarter.
  • OMERS Administration Corp sold 30,300 Cogent Biosciences shares in Q1 2025, an estimated $236K.
  • OMERS Administration Corp first reported a position in Cogent Biosciences in Q4 2024 and held it in 1 quarter.
  • OMERS Administration Corp's Cogent Biosciences position peaked at $236K in Q4 2024.
  • 186 funds tracked by Wall St. Rank held Cogent Biosciences as of Q1 2025.

Based on OMERS Administration Corp's 13F filing for Q1 2025, filed 14 May 2025.